Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Treasury Shares (2016 - 2025)

BioCorRx (BICX) has disclosed Treasury Shares for 13 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 7.45% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 7.45% year-over-year, with the annual reading at $1.3 million for FY2025, 7.45% down from the prior year.
  • Treasury Shares hit $1.3 million in Q4 2025 for BioCorRx, down from $1.5 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.9 million in Q1 2025 to a low of $43334.0 in Q2 2021.
  • Historically, Treasury Shares has averaged $820523.0 across 5 years, with a median of $614151.0 in 2024.
  • Biggest YoY gain for Treasury Shares was 693.32% in 2022; the steepest drop was 81.41% in 2022.
  • Year by year, Treasury Shares stood at $337850.0 in 2021, then soared by 158.71% to $874058.0 in 2022, then soared by 102.03% to $1.8 million in 2023, then dropped by 18.09% to $1.4 million in 2024, then fell by 7.45% to $1.3 million in 2025.
  • Business Quant data shows Treasury Shares for BICX at $1.3 million in Q4 2025, $1.5 million in Q3 2025, and $1.5 million in Q2 2025.